Type 1 diabetes in people hospitalized for COVID-19: new insights from the CORONADO study
figureposted on 28.08.2020 by Matthieu Wargny, Pierre Gourdy, Lisa Ludwig, Dominique Seret-Bégué, Olivier Bourron, Patrice Darmon, Coralie Amadou, Matthieu Pichelin, Louis Potier, Charles Thivolet, Jean-François Gautier, Samy Hadjadj, Bertrand Cariou, the CORONADO investigators
Figures are generally photos, graphs and static images that would be represented in traditional pdf publications.
Since the start of the COVID-19 pandemic, patients with diabetes were rapidly recognized as a high-risk population for severe disease. Indeed, a high prevalence of diabetes among patients with COVID-19 who required hospitalization has been consistently reported, reaching 33.8% in 5,700 people hospitalized for COVID-19 in New York City area (1). In addition, diabetes was associated with more than a double risk of intensive care unit (ICU) admission and more than a triple risk of death (2). However, precise data regarding the type of diabetes are scarce. We report here the clinical characteristics and early prognosis of patients with type 1 diabetes (T1D) hospitalized for COVID-19 in the nationwide multicenter observational CORONADO (CORONAvirus-SARS-CoV-2 and Diabetes Outcomes) study (3).